Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease

计算生物学 神经退行性变 神经炎症 转录组 小RNA
作者
Jielin Xu,Pengyue Zhang,Yin Huang,Yadi Zhou,Yuan Hou,Lynn M. Bekris,Justin Durla Lathia,Chien‐Wei Chiang,Lang Li,Andrew A. Pieper,James B. Leverenz,Jeffrey L. Cummings,Feixiong Cheng
出处
期刊:Genome Research [Cold Spring Harbor Laboratory Press]
卷期号:31 (10): 1900-1912 被引量:85
标识
DOI:10.1101/gr.272484.120
摘要

Abstract Systematic identification of molecular networks in disease relevant immune cells of the nervous system is critical for elucidating the underlying pathophysiology of Alzheimer’s disease (AD). Two key immune cell types, disease-associated microglia (DAM) and disease-associated astrocytes (DAA), are biologically involved in AD pathobiology. Therefore, uncovering molecular determinants of DAM and DAA will enhance our understanding of AD biology, potentially identifying novel therapeutic targets for AD treatment. Here, we present an integrative, network-based methodology to uncover conserved molecular networks between DAM and DAA. Specifically, we leverage single-cell and single-nucleus RNA sequencing data from both AD transgenic mouse models and AD patient brains, drug-target networks, metabolite-enzyme associations, and the human protein-protein interactome, along with large-scale patient data validation from the MarketScan Medicare Supplemental Database. We find that common and unique molecular network regulators between DAM (i.e, PAK1, MAPK14 , and SYK ) and DAA (i.e., NFKB1, FOS , and JUN ) are significantly enriched by multiple neuro-inflammatory pathways and well-known genetic variants (i.e., BIN1 ) from genome-wide association studies. Further network analysis reveal shared immune pathways between DAM and DAA, including Fc gamma R-mediated phagocytosis, Th17 cell differentiation, and chemokine signaling. Furthermore, integrative metabolite-enzyme network analyses imply that fatty acids (i.e., elaidic acid) and amino acids (i.e., glutamate, serine, and phenylalanine) may trigger molecular alterations between DAM and DAA. Finally, we prioritize repurposed drug candidates for potential treatment of AD by agents that specifically reverse dysregulated gene expression of DAM or DAA, including an antithrombotic anticoagulant triflusal, a beta2-adrenergic receptor agonist salbutamol, and the steroid medications (fluticasone and mometasone). Individuals taking fluticasone (an approved anti-inflammatory and inhaled corticosteroid) displayed a significantly decreased incidence of AD (hazard ratio (HR) = 0.858, 95% confidence interval [CI] 0.829-0.888, P < 0.0001) in retrospective case-control validation. Furthermore, propensity score matching cohort studies also confirmed an association of mometasone with reduced incidence of AD in comparison to fluticasone (HR =0.921, 95% CI 0.862-0.984, P < 0.0001).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
NexusExplorer的应助被正直凡灵采纳,获得10
刚刚
刚刚
1秒前
Liew完成签到 ,获得积分10
2秒前
zo发布了新的文献求助10
2秒前
甜美沛容发布了新的文献求助10
2秒前
2秒前
3秒前
木子发布了新的文献求助10
4秒前
4秒前
4秒前
4秒前
5秒前
5秒前
冷傲的白柏完成签到,获得积分10
6秒前
霁月发布了新的文献求助10
7秒前
7秒前
自由的雪一完成签到,获得积分10
7秒前
8秒前
Olive发布了新的文献求助10
8秒前
完美世界的应助被六月雪采纳,获得10
9秒前
9秒前
霁月发布了新的文献求助10
10秒前
10秒前
霁月发布了新的文献求助10
10秒前
霁月发布了新的文献求助10
10秒前
霁月发布了新的文献求助10
10秒前
ZZKKZZ发布了新的文献求助10
10秒前
11秒前
11秒前
12秒前
13秒前
14秒前
所所的应助被dieeee采纳,获得10
14秒前
科研通AI2S的应助被清秀千兰采纳,获得10
15秒前
15秒前
小SCI发布了新的文献求助10
15秒前
15秒前
16秒前
uu发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183694
求助须知:如何正确求助?哪些是违规求助? 9572963
关于积分的说明 21828306
捐赠科研通 7780864
什么是DOI,文献DOI怎么找? 3434057
关于科研通互助平台的介绍 2558257
邀请新用户注册赠送积分活动 2480541